254 related articles for article (PubMed ID: 27598516)
1. Immunological effects of chemotherapy and radiotherapy against brain tumors.
Weiss T; Weller M; Roth P
Expert Rev Anticancer Ther; 2016 Oct; 16(10):1087-94. PubMed ID: 27598516
[TBL] [Abstract][Full Text] [Related]
2. Developing immunotherapeutic strategies to target brain tumors.
Lieberman NA; Moyes KW; Crane CA
Expert Rev Anticancer Ther; 2016 Jul; 16(7):775-88. PubMed ID: 27253692
[TBL] [Abstract][Full Text] [Related]
3. Angiogenesis inhibitors in tackling recurrent glioblastoma.
Hundsberger T; Reardon DA; Wen PY
Expert Rev Anticancer Ther; 2017 Jun; 17(6):507-515. PubMed ID: 28438066
[TBL] [Abstract][Full Text] [Related]
4. Immune-priming of the tumor microenvironment by radiotherapy: rationale for combination with immunotherapy to improve anticancer efficacy.
Shahabi V; Postow MA; Tuck D; Wolchok JD
Am J Clin Oncol; 2015 Feb; 38(1):90-7. PubMed ID: 25616204
[TBL] [Abstract][Full Text] [Related]
5. Harnessing the immune system in glioblastoma.
Brown NF; Carter TJ; Ottaviani D; Mulholland P
Br J Cancer; 2018 Nov; 119(10):1171-1181. PubMed ID: 30393372
[TBL] [Abstract][Full Text] [Related]
6. Immune checkpoint inhibitors with radiotherapy and locoregional treatment: synergism and potential clinical implications.
Esposito A; Criscitiello C; Curigliano G
Curr Opin Oncol; 2015 Nov; 27(6):445-51. PubMed ID: 26447875
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy advances for mesothelioma treatment.
Bakker E; Guazzelli A; Ashtiani F; Demonacos C; Krstic-Demonacos M; Mutti L
Expert Rev Anticancer Ther; 2017 Sep; 17(9):799-814. PubMed ID: 28724330
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy for brain tumors: understanding early successes and limitations.
Lieberman NAP; Vitanza NA; Crane CA
Expert Rev Neurother; 2018 Mar; 18(3):251-259. PubMed ID: 29322843
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapy and immunotherapy: a beneficial liaison?
Weichselbaum RR; Liang H; Deng L; Fu YX
Nat Rev Clin Oncol; 2017 Jun; 14(6):365-379. PubMed ID: 28094262
[TBL] [Abstract][Full Text] [Related]
10. Immunogenic chemotherapy: Dose and schedule dependence and combination with immunotherapy.
Wu J; Waxman DJ
Cancer Lett; 2018 Apr; 419():210-221. PubMed ID: 29414305
[TBL] [Abstract][Full Text] [Related]
11. [What's next in glioblastoma treatment: Tumor-targeted or immune-targeted therapies?].
Schernberg A; Marabelle A; Massard C; Armand JP; Dumont S; Deutsch E; Dhermain F
Bull Cancer; 2016 May; 103(5):484-98. PubMed ID: 27032303
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy in gliomas: Are we reckoning without the innate immunity?
Vismara MFM; Donato A; Malara N; Presta I; Donato G
Int J Immunopathol Pharmacol; 2019; 33():2058738419843378. PubMed ID: 30968718
[TBL] [Abstract][Full Text] [Related]
13. Adapting conventional cancer treatment for immunotherapy.
Qiao J; Liu Z; Fu YX
J Mol Med (Berl); 2016 May; 94(5):489-95. PubMed ID: 26910191
[TBL] [Abstract][Full Text] [Related]
14. Principles of immunotherapy.
Liebelt BD; Finocchiaro G; Heimberger AB
Handb Clin Neurol; 2016; 134():163-81. PubMed ID: 26948354
[TBL] [Abstract][Full Text] [Related]
15. Coley's immunotherapy revived: Innate immunity as a link in priming cancer cells for an attack by adaptive immunity.
Uher O; Caisova V; Hansen P; Kopecky J; Chmelar J; Zhuang Z; Zenka J; Pacak K
Semin Oncol; 2019; 46(4-5):385-392. PubMed ID: 31739997
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy for brain tumors: basic developments and clinical implementation.
Assi H; Candolfi M; Baker G; Mineharu Y; Lowenstein PR; Castro MG
Neurosci Lett; 2012 Oct; 527(2):71-7. PubMed ID: 22906921
[TBL] [Abstract][Full Text] [Related]
17. Immunological consequences of chemotherapy: Single drugs, combination therapies and nanoparticle-based treatments.
Pusuluri A; Wu D; Mitragotri S
J Control Release; 2019 Jul; 305():130-154. PubMed ID: 31004668
[TBL] [Abstract][Full Text] [Related]
18. Cancer Immunotherapy Getting Brainy: Visualizing the Distinctive CNS Metastatic Niche to Illuminate Therapeutic Resistance.
Owyong M; Hosseini-Nassab N; Efe G; Honkala A; van den Bijgaart RJE; Plaks V; Smith BR
Drug Resist Updat; 2017 Nov; 33-35():23-35. PubMed ID: 29145972
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy of Brain Cancer.
Roth P; Preusser M; Weller M
Oncol Res Treat; 2016; 39(6):326-34. PubMed ID: 27260656
[TBL] [Abstract][Full Text] [Related]
20. Basic concepts in glioma immunology.
Parney IF
Adv Exp Med Biol; 2012; 746():42-52. PubMed ID: 22639158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]